670 related articles for article (PubMed ID: 25688144)
1. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
2. Cardiac actions of atrial natriuretic peptide: new visions of an old friend.
Kuhn M
Circ Res; 2015 Apr; 116(8):1278-80. PubMed ID: 25858056
[No Abstract] [Full Text] [Related]
3. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
4. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
Leroy J; Abi-Gerges A; Nikolaev VO; Richter W; Lechêne P; Mazet JL; Conti M; Fischmeister R; Vandecasteele G
Circ Res; 2008 May; 102(9):1091-100. PubMed ID: 18369156
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides: a new lipolytic pathway in human adipocytes.
Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
FASEB J; 2000 Jul; 14(10):1345-51. PubMed ID: 10877827
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.
Götz KR; Sprenger JU; Perera RK; Steinbrecher JH; Lehnart SE; Kuhn M; Gorelik J; Balligand JL; Nikolaev VO
Circ Res; 2014 Apr; 114(8):1235-45. PubMed ID: 24599804
[TBL] [Abstract][Full Text] [Related]
10. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
13. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
[TBL] [Abstract][Full Text] [Related]
14. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
15. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
16. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
Stangherlin A; Zaccolo M
Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
[TBL] [Abstract][Full Text] [Related]
17. Plasma membrane calcium pump (PMCA4)-neuronal nitric-oxide synthase complex regulates cardiac contractility through modulation of a compartmentalized cyclic nucleotide microdomain.
Mohamed TMA; Oceandy D; Zi M; Prehar S; Alatwi N; Wang Y; Shaheen MA; Abou-Leisa R; Schelcher C; Hegab Z; Baudoin F; Emerson M; Mamas M; Di Benedetto G; Zaccolo M; Lei M; Cartwright EJ; Neyses L
J Biol Chem; 2011 Dec; 286(48):41520-41529. PubMed ID: 21965681
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
Mongillo M; Tocchetti CG; Terrin A; Lissandron V; Cheung YF; Dostmann WR; Pozzan T; Kass DA; Paolocci N; Houslay MD; Zaccolo M
Circ Res; 2006 Feb; 98(2):226-34. PubMed ID: 16357307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
